Zinc supplementation improves anticancer activity of monocytes in type-2 diabetic patients with metabolic syndrome.
Randomized controlled trial · Anticancer Res · 2014. Source record refreshed; an explanation has not been reviewed.
About this paper
This page identifies the publication and its source. A checked explanation of its findings is not yet available.
Reading this record
Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.
Publication details
Zinc supplementation improves anticancer activity of monocytes in type-2 diabetic patients with metabolic syndrome.
Meksawan K, Sermsri U, Chanvorachote P
Anticancer Res · 2014
- PubMed ID
- 24403477
- Record checked
A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.
Keep your place in the research.
Save this source or mark it as read.